Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) study

Louise J. Maple-Brown*, Alex Brown, I. Lynn Lee, Christine Connors, Jeremy Oats, Harold D. McIntyre, Cherie Whitbread, Elizabeth Moore, Danielle Longmore, Glynis Dent, Sumaria Corpus, Marie Kirkwood, Stacey Svenson, Paula van Dokkum, Sridhar Chitturi, Sujatha Thomas, Sandra Eades, Monique Stone, Mark Harris, Chrissie InglisKaren Dempsey, Michelle Dowden, Michael Lynch, Jacqueline Boyle, Sue Sayers, Jonathan Shaw, Paul Zimmet, Kerin O'Dea

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Background: Diabetes in pregnancy carries an increased risk of adverse pregnancy outcomes for both the mother and foetus, but it also provides an excellent early opportunity for intervention in the life course for both mother and baby. In the context of the escalating epidemic of chronic diseases among Indigenous Australians, it is vital that this risk is reduced as early as possible in the life course of the individual. The aims of the PANDORA Study are to: (i) accurately assess rates of diabetes in pregnancy in the Northern Territory (NT) of Australia, where 38% of babies are born to Indigenous mothers; (ii) assess demographic, clinical, biochemical, anthropometric, socioeconomic and early life development factors that may contribute to key maternal and neonatal birth outcomes associated with diabetes in pregnancy; and (iii) monitor relevant post-partum clinical outcomes for both the mothers and their babies.Methods/Design: Eligible participants are all NT women with diabetes in pregnancy aged 16 years and over. Information collected includes: standard antenatal clinical information, diagnosis and management of diabetes in pregnancy, socio-economic status, standard clinical birth information (delivery, gestational age, birth weight, adverse antenatal and birth outcomes). Cord blood is collected at the time of delivery and detailed neonatal anthropometric measurements performed within 72 hours of birth. Information will also be collected regarding maternal post-partum glucose tolerance and cardio-metabolic risk factor status, breastfeeding and growth of the baby up to 2 years post-partum in the first instance.Discussion: This study will accurately document rates and outcomes of diabetes in pregnancy in the NT of Australia, including the high-risk Indigenous Australian population. The results of this study should contribute to policy and clinical guidelines with the goal of reducing the future risk of obesity and diabetes in both mothers and their offspring.

Original languageEnglish
Article number221
JournalBMC Pregnancy and Childbirth
Volume13
DOIs
Publication statusPublished - 1 Dec 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) study'. Together they form a unique fingerprint.

Cite this